I agree that this site is using cookies. You can find further informations here.
X
Espenschied, Carin
25  results:
Search for persons X
?
1

A Phase 1/2 Study of Lazertinib 240 mg in Patients With Adv..:

Cho, Byoung Chul ; Han, Ji-Youn ; Kim, Sang-We...
Journal of Thoracic Oncology.  17 (2022)  4 - p. 558-567 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Paired tumor sequencing and germline testing in breast canc..:

Elliott, Elizabeth ; Speare, Virginia ; Coggan, James...
Cancer Reports.  3 (2020)  6 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
3

Monoallelic MUTYH carrier status is not associated with inc..:

Fulk, Kelly ; LaDuca, Holly ; Black, Mary Helen...
Familial Cancer.  18 (2018)  2 - p. 197-201 , 2018
Link: https://doi.org/10.1007/..
 
?
4

TumorNext-Lynch-MMR: a comprehensive next generation sequen..:

Gray, Phillip N. ; Tsai, Pei ; Chen, Daniel...
Oncotarget.  9 (2018)  29 - p. 20304-20322 , 2018
Link: https://doi.org/10.18632..
 
?
5

Secondary Germline Finding in Liquid Biopsy of a Deceased P..:

Veyseh, Maedah ; Ricker, Charite ; Espenschied, Carin...
Frontiers in Oncology.  8 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
6

Hereditary Leukemia Due to Rare RUNX1c Splice Variant (L472..:

Sorrell, April ; Espenschied, Carin ; Wang, Wei...
International Journal of Clinical Medicine.  3 (2012)  7 - p. 607-613 , 2012
Link: https://doi.org/10.4236/..
 
?
7

Advancing Evidence Generation for Circulating Tumor DNA: Le..:

McKelvey, Brittany A. ; Andrews, Hillary S. ; Baehner, Frederick L....
Diagnostics.  14 (2024)  9 - p. 912 , 2024
Link: https://doi.org/10.3390/..
 
?
8

ERBB2 (HER2) amplifications and co-occurring KRAS alteratio..:

Barzi, Afsaneh ; Weipert, Caroline M. ; Espenschied, Carin R....
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
9

Spectrum of driver mutations and clinical impact of circula..:

Mack, Philip C. ; Banks, Kimberly C. ; Espenschied, Carin R....
Cancer.  126 (2020)  14 - p. 3219-3228 , 2020
Link: https://doi.org/10.1002/..
 
?
10

Duration of Targeted Therapy in Patients With Advanced Non–..:

Reckamp, Karen L. ; Patil, Tejas ; Kirtane, Kedar...
Clinical Lung Cancer.  21 (2020)  6 - p. 545-552.e1 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Clinical germline diagnostic exome sequencing for hereditar..:

Powis, Zöe ; Espenschied, Carin R. ; LaDuca, Holly...
Cancer Genetics.  224-225 (2018)  - p. 12-20 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Advances in the diagnosis of hereditary kidney cancer: Init..:

Nguyen, Kevin A. ; Syed, Jamil S. ; Espenschied, Carin R....
Cancer.  123 (2017)  22 - p. 4363-4371 , 2017
Link: https://doi.org/10.1002/..
 
?
13

Spectrum of mismatch repair gene mutations and clinical pre..:

Sunga, Annette Y. ; Ricker, Charité ; Espenschied, Carin R....
Cancer Genetics.  212-213 (2017)  - p. 1-7 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome: ..:

Sorrell, April D. ; Espenschied, Carin R. ; Culver, Julie O..
Molecular Diagnosis & Therapy.  17 (2013)  1 - p. 31-47 , 2013
Link: https://doi.org/10.1007/..
 
?
15

Closing the Loop: Action Research in a Multimodal Hereditar..:

Espenschied, Carin R. ; MacDonald, Deborah J. ; Culver, Julie O....
Journal of Cancer Education.  27 (2012)  3 - p. 467-477 , 2012
Link: https://doi.org/10.1007/..
 
1-15